Endothelial cell confluence regulates Weibel-Palade body formation

References

• Allen, S., Goodeve, A. C., Peake, I. R. and Daly, M. E., 2001, Endoplasmic reticulum retention and prolonged association of a von Willebrand’s disease-causing von Willebrand factor variant with ERp57 and calnexin. Biochem. Biophys. Res. Commun., 280, 448 -453.
   PubMedGoogle Scholar
• Arribas, M. and Cutler, D. F., 2000, Weibel-Palade body membrane proteins exhibit differential trafficking after exocytosis in endothe- lial cells. Traffic, 1, 783 -793.
   PubMedGoogle Scholar
• Arvan, P., Zhang, B. Y., Feng, L., Liu, M. and Kuliawat, R., 2002, Lumenal protein multimerization in the distal secretory pathwayusecretory granules. Curr. Opin. Cell Biol., 14, 448 -453.
   Google Scholar
• Bird, I. N., Taylor, V., Newton, J. P., Spragg, J. H., Simmons, D. L., Salmon, M. and Buckley, C. D., 1999, Homophilic PECAM-1 (CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. J. Cell Sci., 112, 1989 -1997.
   PubMed Web of Science ®Google Scholar
• Blagoveshchenskaya, A. D., Hannah, M. J., Allen, S. and Cutler, D. F., 2002, Selective and signal-dependent recruitment of mem- brane proteins to secretory granules formed by heterologously expressed von Willebrand factor. Mol. Biol. Cell, 13, 1582 -1593.
   Google Scholar
• Blann, A. D., 1991, Increased release of von Willebrand factor antigen by endothelial cells whilst in active growth phase. Cell. Biol. Int. Rep., 15, 493 -498.
   PubMedGoogle Scholar
• Budde, U. and Schneppenheim, R., 2001, Von Willebrand factor and von Willebrand disease. Rev. Clin. Exp. Hematol., 5, 335 -368.
   PubMedGoogle Scholar
• Cartin, W. and Alonso, A., 2003, The human papillomavirus HPV2a E5 protein localizes to the Golgi apparatus and modulates signal transduction. Virology, 314, 572 -579.
   PubMed Web of Science ®Google Scholar
• Colanzi, A., Sutterlin, C. and Malhotra, V., 2003, RAF1-activated MEK1 is found on the Golgi apparatus in late prophase and is required for Golgi complex fragmentation in mitosis. J. Cell Biol., 161, 27 -32.
   PubMedGoogle Scholar
• Cross, M. J., Dixelius, J., Matsumoto, T. and Claesson-Welsh, L., 2003, VEGF-receptor signal transduction. Trends Biochem. Sci., 28, 488 -494.
   PubMed Web of Science ®Google Scholar
• Grewal, S., Morrison, E. E., Ponnambalam, S. and Walker, J. H., 2002, Nuclear localisation of cytosolic phospholipase A2-a in the EA.hy.926 human endothelial cell line is proliferation dependent and modulated by phosphorylation. J. Cell Sci., 115, 4533 -4543.
   Google Scholar
• Haberichter, S. L., Jacobi, P. and Montgomery, R. R., 2003, Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage. Blood, 101, 1384 -1391.
   PubMedGoogle Scholar
• Hannah, M. J., Williams, R., Kaur, J., Hewlett, L. J. and Cutler, D. F., 2002, Biogenesis of Weibel-Palade bodies. Semin. Cell Dev. Biol., 13, 313 -324.
   PubMedGoogle Scholar
• Harlow, E. and Lane, D. P., 1988, Antibodies. A laboratory manual. (Cold Spring Harbor, New York).
   Google Scholar
• Jaffe, E. A., 1984, Biology of endothelial cells (Martinus-Nijhoff, Boston).
   Google Scholar
• Kiyonaga, H., Doi, Y., Karasaki, Y., Arashidani, K., Itoh, H. and Fujimoto, S., 2001, Expressions of endothelin-1, fibronectin, and interleukin-1a of human umbilical vein endothelial cells under prolonged culture. Med. Electron Microsc., 34, 41 -53.
   PubMedGoogle Scholar
• Lip, G. Y. and Blann, A., 1997, von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc. Res., 34, 255 -265.
   PubMed Web of Science ®Google Scholar
• Lopes, A. A., Peranovich, T. M., Maeda, N. Y. and Bydlowski, S. P., 2001, Differential effects of enzymatic treatments on the storage and secretion of von Willebrand factor by human endothelial cells. Thromb. Res., 101, 291 -297.
   PubMedGoogle Scholar
• Mannucci, P. M., 1998, von Willebrand factor: a marker of endothe- lial damage? Arterioscler. Thromb. Vasc. Biol., 18, 1359–1362.
   PubMed Web of Science ®Google Scholar
• Prescott, A. R., Lucocq, J. M., James, J., Lister, J. M. and Ponnambalam, S., 1997, Distinct compartmentalization of TGN46 and a1,4-galactosyltransferase in HeLa cells. Eur. J. Cell Biol., 72, 238 -246.
   PubMed Web of Science ®Google Scholar
• Ruggeri, Z. M., 2003, Von Willebrand factor. Curr. Opin. Hematol., 10, 142 -149.
   PubMed Web of Science ®Google Scholar
• Sadler, J. E., 1998, Biochemistry and genetics of von Willebrand factor. Annu. Rev. Biochem., 67, 395 -424.
   PubMed Web of Science ®Google Scholar
• Sporn, L. A., Marder, V. J. and Wagner, D. D., 1986, Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell, 46, 185 -190.
   PubMed Web of Science ®Google Scholar
• Takeuchi, M., Nagura, H. and Kaneda, T., 1988, DDAVP and epinephrine-induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa. Blood, 72, 850 -854.
   PubMed Web of Science ®Google Scholar
• Towler, M. C., Prescott, A. R., James, J., Lucocq, J. M. and Ponnambalam, S., 2000, The manganese cation disrupts mem- brane dynamics along the secretory pathway. Exp. Cell Res., 259, 167 -179.
   PubMedGoogle Scholar
• Tsai, T. C. and Chen, S. L., 2003, The biochemical and biological functions of human papillomavirus type 16 E5 protein. Arch. Virol., 148, 1445 -1453.
   PubMedGoogle Scholar
• van Mourik, J. A., Boertjes, R., Huisveld, I. A., Fijnvandraat, K., Pajkrt, D., van Genderen, P. J. and Fijnheer, R., 1999, von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturba- tion. Blood, 94, 179 -185.
   PubMed Web of Science ®Google Scholar
• van Mourik, J. A., Romani de Wit, T. and Voorberg, J., 2002, Biogenesis and exocytosis of Weibel-Palade bodies. Histochem. Cell Biol., 117, 113 -122.
   Google Scholar
• Vischer, U. M., Jornot, L., Wollheim, C. B. and Theler, J. M., 1995, Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells. Blood, 85, 3164 -3172.
   PubMed Web of Science ®Google Scholar
• Vischer, U. M. and Wagner, D. D., 1993, CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood, 82, 1184 -1191.
   PubMed Web of Science ®Google Scholar
• Vischer, U. M. and Wollheim, C. B., 1997, Epinephrine induces von Willebrand factor release from cultured endothelial cells: Involve- ment of cyclic AMP-dependent signalling in exocytosis. Thromb. Haemost., 77, 1182–1188.
   PubMedGoogle Scholar
• Vischer, U. M. and Wollheim, C. B., 1998, Purine nucleotides induce regulated secretion of von Willebrand factor: Involvement of cytosolic Ca2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis. Blood, 91, 118 -127.
   PubMedGoogle Scholar
• Wagner, D. D., Mayadas, T. and Marder, V. J., 1986, Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor. J. Cell Biol., 102, 1320 -1324.
   PubMedGoogle Scholar